A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease
This study has been completed.
Sponsor:
NeuroNova AB
Collaborators:
Medtronic
Quintiles
Information provided by (Responsible Party):
NeuroNova AB
ClinicalTrials.gov Identifier:
NCT00866502
First received: March 18, 2009
Last updated: December 5, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2011 |
| Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |